The present invention relates to the field of medicine and pharmacology, specifically to new acetylleucine combinations having at least one substance selected from the group consisting of betahistine, buspirone, choline alfoscerate, and citicoline, for treating vestibular and non-vestibular dizziness, cerebellar ataxia, and familial ataxia.